Onctic Therapeutics (476060) continued its strong momentum, recording double-digit gains even amid a broad market decline in the KOSDAQ.

According to the Korea Exchange on the 16th, Onctic Therapeutics closed at 14,500 won, up 2,450 won (20.33%) from the previous trading day. After the market close, on Nextrade (NXT), it traded at 13,710 won, lower than the regular session's closing price, but still maintained a gain of 1,660 won (13.78%) compared to the previous day.

On the same day, the KOSDAQ market closed at 791.84, down 37.59 points (4.53%), falling below the 800 mark amid shrinking investor sentiment. Selling pressure spread mainly across semiconductor and growth stocks, leading to a broad, sharp correction in the index. However, contrary to the market trend, buying interest flowed into Onctic Therapeutics, allowing it to maintain its intraday gains and attract investor attention. The differentiated movement of an individual stock stood out against an overall contracting market environment.

Investors' attention is now turning to Monday's session following the weekend. Whether this sharp rally will lead to further gains or face profit-taking sell-offs is the key focus.

Analysts note that with semiconductor stocks recently struggling in the U.S. market, it is also necessary to monitor how global stock market volatility and changes in investor sentiment will affect domestic biotech stocks overall.

[※ Investors are solely responsible for their investment decisions, and it is essential to review relevant disclosures and company fundamentals before investing.]